Novus Biologicals Introduces New Post-translationally Modified Survivin Antibody

Novus Biologicals just launched a new Survivin Antibody (NBP1-47639) that is made to a synthetic peptide surrounding the acetylated lysine 129 of the human Survivin protein.

Online PR News – 13-November-2010 – – Cambridge, United Kingdom (29 October 2010) - Novus Biologicals just launched a new Survivin Antibody (NBP1-47639) that is made to a synthetic peptide surrounding the acetylated lysine 129 of the human Survivin protein. It has recently been shown that Survivin acetylation at amino acid 129 affects its interaction with STAT3, determines its interaction with CRM1 and its subsequent subcellular localization (PMID: 20826784).

The new acetylated survivin antibody has been positively validated for use in immunofluorescence, immunohistochemistry and Western blot analysis. By Western blot on TSA treated HeLa cells, a band is seen at approximately 16.5kDa. This Survivin [acetyl 129] antibody reacts with human and has not been tested for cross-reactivity in other species.

Novus provides a wide variety of Survivin antibodies - view the Survivin Antibody list here or browse only post-translationally modified Survivin antibodies here.

For more information on this new Survivin [acetyl K129] Antibody or to inquire about product collaborations, please contact the Novus Product Development Team by calling 303-730-1950 or via e-mail at collaborations@novusbio.com.

For more details about Novus Biologicals, please visit their website at http://www.novusbio.com, or call +44 (0)1223 426001 (Europe) or 1-888-50-NOVUS (USA).

About Novus Biologicals:
Novus Biologicals is an international scientific company, helping to accelerate the advancement of scientific discoveries by developing and commercialising new products in scientific and biological fields. By promoting and commercialising unique biological materials and products to the biological research community, Novus plays an important part in helping to advance international biological research practices. Novus is also constantly monitoring emerging scientific trends and strives to supply products for their advancement.

Contact Details:
Amy Chamberlain-Torres, MBA
Product Marketing Manager
Novus Biologicals Europe
12 Cambridge Science Park
Cambridge, CB4 0FQ, UK
Tel: +44 (0)1223 426001
Fax: +44 (0)871 971 1635
Email: europe@novusbio.com

Novus Biologicals Worldwide
PO Box 802
Littleton, CO 80160 USA
Tel: 1-888-50-NOVUS
Fax: 303-730-1966

Email: novus@novusbio.com

Bookmarkse-mailGoogledel.icio.usStumbleUponSlashdotFurlDiggTechnoratiYahooMyWebBlinkListSpurlRawSugarWists
 
 
Contact Information
Amy Chamberlain
12 Cambridge Science Park
Cambridge Cambridge, CB4 0FQ

+44 (0)1223 426001